Diffuse skin reaction in a patient with hepatitis B, treated with two different formulations of pegylated interferon

Canadian Journal of Gastroenterology

Volumn 19, Issue 11, 2005, Pages 677-678

  Milkiewicz, Piotr ^a,b   Yim, Colina ^a   Pache, Isabelle ^a   Heathcote, Jenny ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Hepatitis B; Pegylated interferon; Skin reaction

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; LAMIVUDINE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; STEROID; UNITRON PEG; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; DRUG ERUPTION; DRUG FORMULATION; DRUG RESPONSE; DRUG WITHDRAWAL; ERYTHEMA; HEPATITIS B; HUMAN; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; PRURITUS; SKIN MANIFESTATION; URTICARIA; VIRUS HEPATITIS; VIRUS REACTIVATION;

EID: 29544431600     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/298403     Document Type: Article

References (6)

1. Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2004;351:1206-17.
2. Lok AS, McMahon BJ. Chronic hepatitis B: Update of recommendations. Hepatology 2004;39:857-61.
3. Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997;26:112S-21S.
4. Sparsa A, Loustaud-Ratti V, Liozon E, et al. Cutaneous reactions or necrosis from interferon alpha: Can interferon be reintroduced after healing? Six case reports. Rev Med Interne 2000;21:756-63.
5. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: A series of 20 patients. Br J Dermatol 2002;147:1142-6.
6. Asnis LA, Gaspari AA. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995;33:393-410.